← Evidence map

ReviewBiomedicines2026

Sucralose and the Gut-Immune Axis: Emerging Evidence Linking Dysbiosis, Barrier Alterations, and Implications for Colitis and Colorectal Cancer Immunotherapy.

Aranza Mejía-Muñoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Sucralose and the Gut-Immune Axis: Emerging Evidence Linking Dysbiosis, Barrier Alterations, and Implications for Colitis and Colorectal Cancer Immunotherapy. | Socratic